Pathway Name | Organism |
---|---|
E.coli O112ab | Escherichia coli |
RES 1b:a-lido-HEX-1:5|6:a
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
24838988 | Anticoagulant motifs of marine sulfated glycans | Pomin VH | 2014 May 20 |
|
24271188 | Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity | Sterner E | 2013 Nov 23 |
|
23756834 | The ovine newborn and human foetal intervertebral disc contain perlecan and aggrecan variably substituted with native 7D4 CS sulphation motif: spatiotemporal immunolocalisation and co-distribution with Notch-1 in the human foetal disc | Shu C | 2013 Jun 13 |
|
24310917 | Novel mineralized heparin–gelatin nanoparticles for potential application in tissue engineering of bone | Yang Y | 2013 Dec 06 |
|
23959878 | Human α- <scp>l</scp> -iduronidase uses its own N -glycan as a substrate-binding and catalytic module | Maita N | 2013 Aug 19 |
|
22900939 | Synthesis and Scalable Conversion of <scp>l</scp>-Iduronamides to Heparin-Related Di- and Tetrasaccharides | Hansen SU | 2012 Sep 04 |
|
22442151 | Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix | Lortat-Jacob H | 2012 May 25 |
|
22402327 | Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I | Dickson PI | 2012 May |
|
22528493 | Uncovering Biphasic Catalytic Mode of C5-epimerase in Heparan Sulfate Biosynthesis | Sheng J | 2012 Jun 15 |
|
22350411 | Dermatan Sulfate Is Involved in the Tumorigenic Properties of Esophagus Squamous Cell Carcinoma | Thelin MA | 2012 Apr 15 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025